Larissa Yuri Ishizu, Filipy Borghi, Ana Gabriela Conceição-Vertamatti, Gustavo Trevisan Costa, Luiz Alberto Ramos, Miguel Arcanjo Área, Dora Maria Grassi-Kassisse
{"title":"高血压大鼠交感神经张力和下丘脑-垂体-肾上腺(HPA)轴激活对代谢参数的影响","authors":"Larissa Yuri Ishizu, Filipy Borghi, Ana Gabriela Conceição-Vertamatti, Gustavo Trevisan Costa, Luiz Alberto Ramos, Miguel Arcanjo Área, Dora Maria Grassi-Kassisse","doi":"10.1016/j.endmts.2021.100112","DOIUrl":null,"url":null,"abstract":"<div><p>Increased activity of the sympathetic nervous system (SNS) may play an important role in the development of hypertension and in adiposity disorders. We aimed to investigate the influence of increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation in metabolic parameters by evaluating the morphometry of isolated adipocytes from different fat pads and energy consumption. Serum levels of catecholamines, HPA hormones, T3 and adipokines were measured in 15-weeks-old Wistar (WIS), Wistar-Kyoto (WKY), Spontaneously Hypertensive Rats (SHR) and WIS treated with <em>N</em><sup>G</sup>-nitro-L-arginine methyl ester (L-NAME). L-NAME and SHR showed a reduced adiposity when compared to their controls, which may be related to higher concentrations of T3. However, SHR presented the most evident lipodystrophy, presenting significant changes in the morphometry from isolated adipocytes and the production of adipokines. Thus, our study suggests that endocrine changes in hypertension models may highlight possible therapeutic targets in the treatment of metabolic changes associated with hypertension.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100112","citationCount":"0","resultStr":"{\"title\":\"Increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation impact in metabolic parameters from hypertensive rats\",\"authors\":\"Larissa Yuri Ishizu, Filipy Borghi, Ana Gabriela Conceição-Vertamatti, Gustavo Trevisan Costa, Luiz Alberto Ramos, Miguel Arcanjo Área, Dora Maria Grassi-Kassisse\",\"doi\":\"10.1016/j.endmts.2021.100112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Increased activity of the sympathetic nervous system (SNS) may play an important role in the development of hypertension and in adiposity disorders. We aimed to investigate the influence of increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation in metabolic parameters by evaluating the morphometry of isolated adipocytes from different fat pads and energy consumption. Serum levels of catecholamines, HPA hormones, T3 and adipokines were measured in 15-weeks-old Wistar (WIS), Wistar-Kyoto (WKY), Spontaneously Hypertensive Rats (SHR) and WIS treated with <em>N</em><sup>G</sup>-nitro-L-arginine methyl ester (L-NAME). L-NAME and SHR showed a reduced adiposity when compared to their controls, which may be related to higher concentrations of T3. However, SHR presented the most evident lipodystrophy, presenting significant changes in the morphometry from isolated adipocytes and the production of adipokines. Thus, our study suggests that endocrine changes in hypertension models may highlight possible therapeutic targets in the treatment of metabolic changes associated with hypertension.</p></div>\",\"PeriodicalId\":34427,\"journal\":{\"name\":\"Endocrine and Metabolic Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100112\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine and Metabolic Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666396121000352\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine and Metabolic Science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666396121000352","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
交感神经系统(SNS)活动的增加可能在高血压和肥胖疾病的发展中起重要作用。我们的目的是通过评估不同脂肪垫和能量消耗的离体脂肪细胞的形态测量来研究交感神经张力增加和下丘脑-垂体-肾上腺(HPA)轴激活对代谢参数的影响。用ng -硝基- l -精氨酸甲酯(L-NAME)治疗15周龄Wistar (WIS)、Wistar- kyoto (WKY)、自发性高血压大鼠(SHR)和WIS,测定血清儿茶酚胺、HPA激素、T3和脂肪因子水平。与对照组相比,L-NAME和SHR组的肥胖程度有所降低,这可能与较高浓度的T3有关。然而,SHR表现出最明显的脂肪营养不良,从分离的脂肪细胞形态和脂肪因子的产生中表现出显著的变化。因此,我们的研究表明,高血压模型中的内分泌变化可能在治疗与高血压相关的代谢变化中突出可能的治疗靶点。
Increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation impact in metabolic parameters from hypertensive rats
Increased activity of the sympathetic nervous system (SNS) may play an important role in the development of hypertension and in adiposity disorders. We aimed to investigate the influence of increased sympathetic tone and hypothalamic–pituitary–adrenal (HPA) axis activation in metabolic parameters by evaluating the morphometry of isolated adipocytes from different fat pads and energy consumption. Serum levels of catecholamines, HPA hormones, T3 and adipokines were measured in 15-weeks-old Wistar (WIS), Wistar-Kyoto (WKY), Spontaneously Hypertensive Rats (SHR) and WIS treated with NG-nitro-L-arginine methyl ester (L-NAME). L-NAME and SHR showed a reduced adiposity when compared to their controls, which may be related to higher concentrations of T3. However, SHR presented the most evident lipodystrophy, presenting significant changes in the morphometry from isolated adipocytes and the production of adipokines. Thus, our study suggests that endocrine changes in hypertension models may highlight possible therapeutic targets in the treatment of metabolic changes associated with hypertension.